Analysis of Antibody Responses of Vaccinated Persons with Coronavac
Aydin BALCI +2 more
openaire +1 more source
Reply to Mungmunpuntipantip and Wiwanitkit: CoronaVac or BNT162b2 Vaccine as a Third Dose
Chris Ka Pun Mok +2 more
openaire +2 more sources
Absence of autoantibodies linked to cancer and autoimmune disorders 26 weeks after BNT162b2 boosting in CoronaVac- primed individuals. [PDF]
Mat Yassim AS +6 more
europepmc +1 more source
Modeling of antibody waning after heterologous boosting with Ad5-nCoV in individuals primed with two-dose CoronaVac previously. [PDF]
Shen R +5 more
europepmc +1 more source
Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance study. [PDF]
Costa LB +9 more
europepmc +1 more source
Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil. [PDF]
Borges MC +24 more
europepmc +1 more source
Baseline cohort profile: clinical and molecular characterisation of SARS-CoV-2 infected patients recruited into a longitudinal COVID-19 cohort study (COVGEN) in Malaysia. [PDF]
Azami NAM +29 more
europepmc +1 more source
The Impact of COVID-19 Vaccination on HR-HPV Persistence and Cervical Cytology Outcomes: A Retrospective Study. [PDF]
Şahin M, Arslanca T.
europepmc +1 more source
Identification of metabolic signatures of immune response following mRNA and inactivated vaccines against COVID-19: a systematic review. [PDF]
Wasilewski A, Serrafi A.
europepmc +1 more source
Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort. [PDF]
Oluka GK +9 more
europepmc +1 more source

